Sudeshna Mukherjee

Prof. Sudeshna Mukherjee


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
KLK. Lohitesh
K. Lohitesh
RCRajdeep Chowdhury
Rajdeep Chowdhury
SMSudeshna Mukherjee
Sudeshna Mukherjee
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality, accounting for almost 90% of total liver cancer burden. Surgical resection followed by adjuvant and systemic chemotherapy are the most meticulously followed treatment procedures but the complex etiology and high metastatic potential of the disease renders surgical treatment futile in majority of the cases. Another hindrance to the scenario is the acquired resistance to drugs resulting in relapse of the disease. Hence, to provide insights into development of novel therapeutic targets and diagnostic biomarkers, this review focuses on the various molecular mechanisms underlying chemoresistance in HCC. We have provided a comprehensive summary of the various strategies adopted by HCC cells, extending from apoptosis evasion, autophagy activation, drug expulsion to epigenetic transformation as modes of therapy resistance. The role of stem cells in imparting chemoresistance is also discussed. Furthermore, the review also focuses on how this knowledge might be exploited for the development of an effective, prospective therapy against HCC.

4 January 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
SDSubhra Dash
Subhra Dash
PSPrasad M. Sarashetti
Prasad M. Sarashetti
BRBalaji Rajashekar
Balaji Rajashekar
RCRajdeep Chowdhury
Rajdeep Chowdhury
SMSudeshna Mukherjee
Sudeshna Mukherjee
TGF-2-induced EMT is dampened by inhibition of autophagy and TNF- treatment TGF-β2-induced EMT is dampened by inhibition of autophagy and TNF-α treatment

1 February 2021 in Cytokine
Verified
Journal Article
Closed access
SDSubhra Dash
Subhra Dash
ASAnirudha K. Sahu
Anirudha K. Sahu
ASAbhilasha Srivastava
Abhilasha Srivastava
RCRajdeep Chowdhury
Rajdeep Chowdhury
SMSudeshna Mukherjee
Sudeshna Mukherjee

1 November 2022 in Toxicology Reports
Verified
Journal Article
Open access
SDSmita Dey
Smita Dey
LFLeena Fageria
Leena Fageria
ASAnkita Sharma
Ankita Sharma
SMSudeshna Mukherjee
Sudeshna Mukherjee
SPSurojit Pande
Surojit Pande
SCShibasish Chowdhury
Shibasish Chowdhury
Breast cancer is one of the most frequent forms of cancer. Although different treatment modalities are available, none has proved to be a game-changer. In this context, nanomedicine is one of the hot research areas, with different nano-formulations being explored as a therapeutic strategy against breast cancer. Herein, silver nanoparticles (AgNPs) have shown prospects with their anti-tumor properties and are currently being explored aggressively; however, the underlying molecular mechanisms of AgNP action remain to be unearthed. As part of this study, human breast cancer cells- MCF7 were exposed to AgNPs (∼9 nm), and the effect of the same was explored on mitochondrial and endoplasmic reticulum (ER) dynamicity. We observed that the AgNPs co-localize with mitochondria and cause mitochondrial membrane depolarization, ROS generation, and destabilized mitochondrial homeostasis. Also, the NPs were found to enhance ER stress. We further found that increased ER stress is linked to the disruption of mitochondrial dynamics. Overall, our study shows that the AgNPs can effectively cause apoptosis of MCF-7 cells by regulating the mitochondrial-ER dynamicity. The results provide an insight into the mechanisms via which AgNPs act and can be used in developing a potential chemotherapeutic agent.

14 January 2021 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
HSHeena Saini
Heena Saini
HSHarshita Sharma
Harshita Sharma
SMSudeshna Mukherjee
Sudeshna Mukherjee
SCShibasish Chowdhury
Shibasish Chowdhury
RCRajdeep Chowdhury
Rajdeep Chowdhury
Background: Osteosarcoma (OS) is a malignant tumor of the bone mostly observed in children and adolescents. The current treatment approach includes neoadjuvant and adjuvant chemotherapy; however, drug resistance often hinders therapy in OS patients. Also, the post-relapse survival of OS patients is as low as 20%. We therefore planned to understand the molecular cause for its poor prognosis and design an appropriate therapeutic strategy to combat the disease.Methods: We analyzed OS patient dataset from Gene Expression Omnibus (GEO) and identified the differentially expressed genes and the top deregulated pathways in OS. Subsequently, drugs targeting the major de-regulated pathways were selected and the following assays were conducted- MTT assay to assess cytotoxicity of drugs in OS cells; immunoblotting and immunostaining to analyze key protein expression and localization after drug treatment; LysoTracker staining to monitor lysosomes; Acridine Orange to label acidic vesicles; and DCFDA to measure Reactive Oxygen Species (ROS).Results: The differential gene expression analysis from OS patient dataset implicated the striking involvement of cellular processes linked to autophagy and protein processing in the development of OS. We therefore selected the FDA approved drugs, chloroquine (CQ) and verteporfin (VP) known for autophagy inhibitory and proteotoxic functions to explore against OS. Importantly, VP, but not CQ, showed an extensive dose-dependent cytotoxicity. It resulted in autophagy disruption at multiple steps extending from perturbation of early autophagic processes, inhibition of autophagic flux to induction of lysosomal instability. Interestingly, VP treated protein lysates showed a ROS-dependent high molecular weight (HMW) band when probed for P62 and P53 protein. Further, VP triggered accumulation of ubiquitinated proteins as well. Since VP had a pronounced disruptive effect on cellular protein homeostasis, we explored the possibility of simultaneous inhibition of the ubiquitin-proteasomal system (UPS) by MG-132 (MG). Addition of a proteasomal inhibitor significantly aggravated VP induced cytotoxicity. MG co-treatment also led to selective targeting of P53 to the lysosomes.Conclusion: Herein, we propose VP and MG induce regulation of autophagy and protein homeostasis which can be exploited as an effective therapeutic strategy against osteosarcoma.

8 July 2021 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
AJAshok Jadon
Ashok Jadon
MAMohammad Amir
Mohammad Amir
NSNeelam Sinha
Neelam Sinha
SCSwastika Chakraborty
Swastika Chakraborty
AAAsif Ahmad
Asif Ahmad
SMSudeshna Mukherjee
Sudeshna Mukherjee
Multimodal analgesia (MMA) is the current standard practice to provide post-cesarean analgesia. The aim of this study was to compare the analgesic efficacy of quadratus lumborum (QL) block and transversus abdominis plane (TAP) block as an adjunct to MMA. Eighty mothers undergoing cesarean delivery under spinal anesthesia were randomized to receive either TAP or transmuscular QL block (QLB) with 20 mL 0.375% ropivacaine on each side. Postoperatively, all the subjects were assessed at 2, 4, 6, 8, 12, 18, and 24 hours. The primary outcome was the time to first analgesic request. The secondary outcomes were the pain scores during rest and movement, number of doses of tramadol, postoperative nausea-vomiting, sedation, and mother's satisfaction with the pain management. The median (IQR) time to first analgesic request was 12 (9.25, 13) hours in the QL group and 9 (8.25, 11.37) hours in the TAP group (p = 0.0008). Patients in QL group consumed less doses of tramadol than those in TAP group (p < 0.0001). Pain scores were significantly lower in the QL group at all time points (p < 0.0001) except at 8th hour when at rest, p = 0.0024, and on movement, p = 0.0028. The maternal satisfaction was significantly higher in the QL group (p = 0.0017). Our study showed the significant delay in time to first analgesic request in QL group patients. Patients in the QL group had lower pain scores, required fewer analgesic supplements, and had more satisfaction. Nausea-vomiting and sedation were comparable.